State Street Corporation 13D and 13G filings for Emergent BioSolutions Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-09 06:33 am Purchase | 2025-12-31 | 13G | Emergent BioSolutions Inc. EBS | STATE STREET CORP STT | 2,696,375 5.100% | 1,633,424 (+153.67%) | Filing |
| 2024-01-23 10:52 am Sale | 2023-12-31 | 13G | Emergent BioSolutions Inc. EBS | STATE STREET CORP STT | 1,062,951 2.050% | -69,004 (-6.10%) | Filing |
| 2023-10-10 11:27 am Sale | 2023-09-30 | 13G | Emergent BioSolutions Inc. EBS | STATE STREET CORP STT | 1,131,955 2.180% | -4,686,000 (-80.54%) | Filing |
| 2023-01-10 08:13 am Purchase | 2022-12-31 | 13G | Emergent BioSolutions Inc. EBS | STATE STREET CORP STT | 5,817,955 11.660% | 2,785,228 (+91.84%) | Filing |
| 2022-02-10 1:58 pm Purchase | 2021-12-31 | 13G | Emergent BioSolutions Inc. EBS | STATE STREET CORP STT | 3,032,727 5.640% | 3,032,727 (New Position) | Filing |